Acute kidney injury (AKI) is a common clinical syndrome with limited treatment options and
high mortality rates. Proximal tubular epithelial cells (PTECs) play a key role in AKI …

… emerging nanodrugs that exploit the pathological and physiological features of the kidney to
… used to improve renal targeting and reviewed advances of nanodrugs for AKI: nano-RONS-…

… nanodrugs passively or actively targeting the glomerular filtration barrier (GFB) in AKI
treatments. Then, engineered nanodrugs … for the clinical application of engineered nanodrugs for …

… and future trajectories of renal nanomedicine research for AKI … We then introduce the
application of NDCs in renal drug … Lastly, we critically review the application of NDCs to the in vivo …

… We then summarize the application of nanomedicine in AKI … how to realize the application
of nanomedicine in the treatment … Finally, we also discuss the application of nanomedicines to …

… nanomedicines in the application … kidney repair or recovery from AKI. The review provides
insights into the synthesis, advantages, and limitations of innovative nanomedicine application …

… Up to now, no nanomedicine products have obtained the clinical use approval for AKI …
clinical application of these nanomedicines on patients. The action mechanism of nanomedicine …

… Acute kidney injury (AKI) is a serious kidney disease without specific … Besides, kidney-targeted
drugs are not common and small … We will discuss the application of active targeting in AKI …

… kidney function protection and recovery after injury complex. This also lays the foundation for
the application of nanomedicine in kidney … of kidney injury during acute kidney injury (AKI) …

… Acute kidney injury complicates severe illness and can lead to death or chronic kidney … the
complex environment of care around acute kidney injury. These data support the rodent and …